Sanofi (SNY) to Release Earnings on Thursday

Sanofi (NASDAQ:SNY) will be releasing its earnings data before the market opens on Thursday, April 25th. Analysts expect Sanofi to post earnings of $0.99 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Sanofi (NASDAQ:SNY) last released its quarterly earnings data on Thursday, February 1st. The company reported $0.89 EPS for the quarter, missing the consensus estimate of $0.94 by ($0.05). Sanofi had a net margin of 12.56% and a return on equity of 27.47%. The business had revenue of $11.76 billion for the quarter, compared to analysts’ expectations of $13.02 billion. On average, analysts expect Sanofi to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Sanofi Stock Performance

NASDAQ SNY opened at $47.15 on Tuesday. Sanofi has a 12-month low of $42.63 and a 12-month high of $57.82. The firm has a market cap of $119.27 billion, a P/E ratio of 19.98, a price-to-earnings-growth ratio of 1.62 and a beta of 0.61. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The company’s 50 day moving average is $47.54 and its 200-day moving average is $48.50.

Sanofi Increases Dividend

The company also recently declared an annual dividend, which will be paid on Thursday, June 6th. Stockholders of record on Friday, May 10th will be issued a $1.478 dividend. The ex-dividend date is Thursday, May 9th. This represents a dividend yield of 2.98%. This is a boost from Sanofi’s previous annual dividend of $1.38. Sanofi’s dividend payout ratio is presently 62.29%.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on SNY shares. TheStreet downgraded Sanofi from a “b” rating to a “c” rating in a research report on Friday, February 9th. StockNews.com lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Finally, Morgan Stanley started coverage on Sanofi in a research note on Tuesday, January 23rd. They set an “equal weight” rating and a $55.00 price target for the company. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $55.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.